Related Experiment Videos
Thrombolysis in acute ischaemic stroke.
A C Pereira1, P J Martin, E A Warburton
1Department of Clinical Neurology, Ipswich Hospital, Ipswich, UK.
Postgraduate Medical Journal
|February 27, 2001
Summary
Thrombolysis with recombinant tissue plasminogen activator (rtPA) is safe for stroke patients within six hours, but effective only within three hours. Improved imaging may enhance treatment targeting for better stroke outcomes.
Area of Science:
- Neurology
- Emergency Medicine
- Radiology
Background:
- Stroke thrombolysis with rtPA is a critical intervention.
- Current guidelines recommend rtPA administration within a specific time window.
Purpose of the Study:
- To evaluate the safety and efficacy of rtPA in acute stroke.
- To explore potential improvements in patient selection for thrombolysis.
Main Methods:
- Review of existing data on rtPA use in acute stroke.
- Discussion of advanced imaging techniques like MRI for stroke assessment.
Main Results:
- rtPA is safe within six hours but effective primarily within three hours of stroke onset.
- Only a small percentage (6%-12%) of stroke patients are currently eligible for thrombolysis.
Conclusions:
- Early assessment and referral are crucial for timely stroke treatment decisions.
- Advanced imaging techniques may improve targeting of rtPA to maximize patient benefit.
- Increased thrombolysis use will necessitate significant changes in stroke service delivery.